Renovaro Biosciences Inc.

Symbol: RENB

NASDAQ

1.2

USD

Market price today

  • 0.0000

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 172.40M

    MRK Cap

  • 0.00%

    DIV Yield

Renovaro Biosciences Inc. (RENB) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.00%

Operating Profit Margin

0.00%

Net Profit Margin

0.00%

Return on Assets

0.00%

Return on Equity

0.00%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Hon. Mark R. Dybul M.D.
Full-time employees:12
City:Los Angeles
Address:2080 Century Park East
IPO:2018-02-07
CIK:0001527728

Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. Renovaro Biosciences Inc. is headquartered in Los Angeles, California.

security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Renovaro Biosciences Inc. (RENB) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 0.000 in 2024.

What is the ticker symbol of Renovaro Biosciences Inc. stock?

The ticker symbol of Renovaro Biosciences Inc. stock is RENB.

What is company IPO date?

IPO date of Renovaro Biosciences Inc. is 2018-02-07.

What is company current share price?

Current share price is 1.200 USD.

What is stock market cap today?

The market cap of stock today is 172401600.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 12.